Incidence of Newly Diagnosed Type 1 Diabetes Mellitus in Children and Adolescents in Henan Province of China from 2017 to 2020: A Retrospective Multicenter Study Based on Hospitalization Data

Chen, Qiong; Xu, Ning; Chen, Yongxing; Yan, Mingming; Tian, Fang; Yang, Wei; Cui, Yan; Huang, An; Li, Yangshiyu; Zhang, He; Jiang, Zhihong; Zheng, Ruizhi; Yuan, Jian; Zhang, Dongming; Ren, Qiao; Li, Ding; Wei, Haiyan

doi:10.4274/jcrpe.galenos.2022.2022-12-4

Cited by 3 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nishioka and colleagues reported that in Japan, the incidence of T1DM in patients aged 0–19 for men was 3.94/100,000 person-years, while that for women was 5.22/100,000 person-years [ 36 ]. A study from China’s Henan province showed that the female-to-male incidence rate ratio was 1.32 (95% CI 1.20, 1.45) in the 0–14 years age group [ 37 ]. In this study, the male-to-female ratio of the incidence of T1DM was 1:1.31, which was consistent with previous studies.…”

Section: Discussionmentioning

confidence: 99%

Incidence of Childhood Type 1 Diabetes in Beijing During 2011–2020 and Predicted Incidence for 2025–2035: A Multicenter, Hospitalization-Based Study

Qian

et al. 2023

Diabetes Ther

View full text Add to dashboard Cite

Introduction China has a low incidence of type 1 diabetes mellitus (T1DM); however, based on the large population, the absolute numbers are high. Our aim was to assess the incidence of childhood T1DM in Beijing during 2011–2020, predicted incidence for 2025–2035, and to determine the incidence of diabetic ketosis or diabetic ketoacidosis (DK/DKA) in this population. Methods Data on patients aged less than 15 years of age with newly diagnosed T1DM between January 1, 2011 and December 31, 2020 was obtained from five tertiary hospitals in Beijing and retrospectively analyzed. Results In all, 636 children aged less than 15 years were diagnosed with T1DM during 2011–2020. The incidence of T1DM was 3.11–5.46 per 100,000 per year, with an average increase of 5.10% per year. The age-specific incidence for ages 0–4 years, 5–9 years, and 10–14 years was 2.97, 4.69, and 4.68 per 100,000 per year, respectively. The highest average annual increase (7.07%) in incidence was for the youngest age group. DK or DKA was present at the time of diagnosis of T1DM in 84.6% of patients. The age-specific incidence of T1DM among children aged less than 15 years was predicted to be 7.32, 11.4, and 11.52 per 100,000 in 2035 for ages 0–4 years, 5–9 years, and 10–14 years, respectively. Conclusions The was a gentle increase in the incidence of childhood T1DM during 2011–2020 in Beijing. This increase is expected to continue for the next 15 years. Supplementary Information The online version contains supplementary material available at 10.1007/s13300-023-01367-8.

show abstract

Section: Discussionmentioning

confidence: 99%

Incidence of Childhood Type 1 Diabetes in Beijing During 2011–2020 and Predicted Incidence for 2025–2035: A Multicenter, Hospitalization-Based Study

Qian

et al. 2023

Diabetes Ther

View full text Add to dashboard Cite

show abstract

Incidence of type 1 diabetes in Gansu Province, Northwest China from 2018 to 2022: a multicenter, hospitalization-based study

Zhang,

Liu,

Yang

et al. 2024

Acta Diabetol

View full text Add to dashboard Cite

Pediatric Type 1 Diabetes: A Bibliometric Analysis of the 100 Most-cited Publications

Dayal,

Gupta,

Mamdapur

et al. 2024

J Diabetol

View full text Add to dashboard Cite

Background: The most impactful research on pediatric type 1 diabetes (T1D) remains unknown. Objective: We aimed to evaluate the characteristics and impact of the 100 most-cited articles on pediatric T1D. Materials and Methods: Using a predefined bibliometric strategy, the Scopus database was searched for high-cited papers (HCPs) published from 2001 to 2020. Articles were evaluated for data on the publication year, countries, authors, journals, topics, and types. Social network analysis was performed to visualize the interaction among countries, organizations, and authors using VOSviewer software. Results: The top 100 HCPs received 390 to 4634 citations, averaging 773.5 citations per paper (CPP). The funded HCPs (n = 50) had a higher impact (CPP 791.5). The majority of HCPs (n = 83) were collaborative. Classifying by research type, 65 studies were clinical (n = 65), risk factors (n = 27), epidemiology (n = 26), pathophysiology (n = 16), treatment outcome (n = 13), genetics (n = 12), complications (n = 3), quality of life (n = 2), and prognosis (n = 1). The number of authors involved was 1,101, affiliated with 545 organizations in 27 countries; the USA (n = 64) and the UK (n = 24) were the most productive countries, whereas Australia and the UK were the most impactful. D.M. Nathan and J.M. Lawrence were the most prolific authors, while P. Raskin and J.M. Lachin were the most impactful. Conclusions: High-income countries such as the USA, UK, and Australia contribute significantly to high-impact pediatric T1D research. Funding and collaboration improve the impact of citations in publications. Less researched areas such as treatment outcomes, genetics, complications, quality of life, and prognosis should be the focus of future research on pediatric T1D.

show abstract

Incidence of Newly Diagnosed Type 1 Diabetes Mellitus in Children and Adolescents in Henan Province of China from 2017 to 2020: A Retrospective Multicenter Study Based on Hospitalization Data

Cited by 3 publications

References 22 publications

Incidence of Childhood Type 1 Diabetes in Beijing During 2011–2020 and Predicted Incidence for 2025–2035: A Multicenter, Hospitalization-Based Study

Incidence of Childhood Type 1 Diabetes in Beijing During 2011–2020 and Predicted Incidence for 2025–2035: A Multicenter, Hospitalization-Based Study

Incidence of type 1 diabetes in Gansu Province, Northwest China from 2018 to 2022: a multicenter, hospitalization-based study

Pediatric Type 1 Diabetes: A Bibliometric Analysis of the 100 Most-cited Publications

Contact Info

Product

Resources

About